speed

Speed up

Gain access to customized, high-quality services to speed up your early R&D process and reduce your time to decision making.
saved_search

Identify

Obtain novel insights into disease biology and identify targets and lead compounds with potential to produce first-in-class medicines.
handshake

Collaborate

Benefit from truly collaborative services where scientific exchange and open communication are prioritized to ensure project success.
Our services

An approach you can trust

We are seasoned drug discovery professionals. Our mission is to create outstanding value for our Clients through highly customized in vitro neurobiology services delivering scientific excellence, innovation, and quality of the highest of standards.
Read more arrow_forward
biotech

Basic research

From deciphering disease mechanisms to exploration of novel assay concepts.
ads_click

Target discovery

Using functional genomics and advanced in vitro models we help our Clients to identify and validate novel targets.
query_stats

Lead discovery

Phenotypic and target-based assay development, screening and lead optimization.
Our platform

Elevated neurobiology in vitro research

Our broad in vitro capabilities build on novel technologies and readouts as well as physiologically relevant biological systems. These provide unique opportunities to identify new targets and classes of compounds in neurobiology.
Read more arrow_forward

News and events

Latest news and insights

Cellectricon values scientific exchange and we invite you to take part of our latest news and to learn about upcoming events.

Read more

Events
April 1-5, 2025
AD/PD 2025
The AD/PD 2025 International Conference on Alzheimer’s and Parkinson’s Diseases and related neurological disorders takes place in Vienna, Austria on...
Events
March 26, 2025
Live webinar - A Translationally Relevant Systems Biology Platform for Neuroinflammation
This webinar takes place on Wednesday March 26th between 16.00 and 16.45 CET / 15.00-15.45 GMT / 11.00-11.45 AM EDT / 8.00-8.45 AM PDT.
News
2025-02-24
FamilieSCN2A Foundation and Cellectricon Announce Strategic Partnership
We are honored to have been selected as a partner to the FamilieSCN2A Foundation and to support their work to...
News
2025-03-03
Characterisation of the antinociceptive effect of baricitinib in the collagen antibody-induced arthritis mouse model
We are happy to announce the publication of “Characterisation of the antinociceptive effect of baricitinib in the collagen antibody-induced arthritis...
Events
February 25-27, 2025
Neuroimmunology Drug Development Summit
The 7th Neuroimmunology Drug Development Summit takes place in Boston, US on February 25-27. As a leading provider of neurobiology...
Events
January 28, 2025
Live webinar: A High-Capacity Neuritogenesis Assay - Advancing Neuroplasticity Research and Drug Discovery
This webinar takes place on Tuesday January 28th between 16.00 and 16.30 CET / 15.00-15.30 GMT / 10.00-10.30 AM EST.
News
2024-12-19
Cellectricon joins SwedenBIO, a non-profit association for Life Science in Sweden
Cellectricon, a services provider dedicated to advancing drug discovery and research in neuroscience, has become a member of SwedenBIO, a...
News
2024-12-13
Cellectricon receives EcoVadis Sustainability Rating
Cellectricon, a services provider dedicated to advancing drug discovery and research in neuroscience, has been awarded a Bronze Medal by...
News
2024-12-04
Development of human in vitro models for the study of pain
In September, Cellectricon welcomed our new coworker Andrea Lovincic Babic to the team. Andrea will carry out her PhD project...

Sign up to get news & events updates from Cellectricon

Read about our Privacy Policy

Social media

Cellectricon on LinkedIn

Follow us on LinkedIn

Webcasts and videos

Check out our YouTube channel to view select webcasts and presentations from our in-house experts and collaborators.

Follow us on YouTube